- Medical School - Aberdeen University (1968-1974)
- Internship - Aberdeen General Hospitals (1974-1975), General Medicine & Neurosurgery
- Residency - Rochester Psychiatric Center (1975-1978), Psychiatry
- Residency - Stanford University Hospital (1978-1980), Child Psychiatry
- Residency - Stanford University Hospital (1980-1981), Child Psychiatry
- Fellowship - Stanford University Hospital (1980-1981), Child Psychiatry
Graham Emslie, M.D.
- Charles E. and Sarah M. Seay Chair in Child Psychiatry
- Psychiatry
Biography
Graham Emslie, M.D., joined the UT Southwestern faculty in 1981. He has served as Director for both the inpatient and outpatient units of Children’s Medical Center’s Psychiatry Division. Dr. Emslie's clinical focus is in child and adolescent depression.
He earned both his undergraduate degree and his medical degree at Aberdeen University in Aberdeen, Scotland. Dr. Emslie performed his internship at Aberdeen Hospitals in general medicine and neurosurgery. He then completed his residency in general psychiatry at the University of Rochester, New York, and in child psychiatry at Stanford University, where he also completed a research fellowship.
Dr. Emslie's research focus is in conducting efficacy and effectiveness trials with medications and psychotherapy for children and adolescents with depression, anxiety disorders, and attention-deficit disorders. He is also involved with developing and evaluating medication algorithm protocols for children and adolescents with depression.
Dr. Emslie is active in several professional organizations, including the American Academy of Child and Adolescent Psychiatry, the American Psychiatric Association, the Texas Society of Child and Adolescent Psychiatry, the Texas Society of Psychiatric Physicians, the Society of Biological Psychiatry, and the International Society for Research in Child and Adolescent Psychopathology. He is past President of the Texas Society of Child and Adolescent Psychiatry.
He is also on several committees, including the National Institute of Mental Health (NIMH) Interventions Committee, the NIMH Child Council Work Group, and the Corporate Contributions and Research Committee for the American Academy of Child and Adolescent Psychiatry.
Dr. Emslie has written over 60 papers and 17 chapters, and serves on the editorial board for the Journal of the American Academy of Child and Adolescent Psychiatry.
He is known internationally for his work in the treatment of pediatric depression, and in 2003, he was awarded The Klingenstein Third Generation Foundation Award for his work in the field.
Education & Training
Professional Associations & Affiliations
- American Academy of Child and Adolescent Psychiatry
- American Psychiatric Association
- Society of Biological Psychiatry
- Texas Society of Child and Adolescent Psychiatry
- Texas Society of Psychiatric Physicians
Honors & Awards
- Klingenstein Third Generation Foundation Award for Research in Depression or Suicide 2003
- Joseph Fischhoff, M.D., Honorary Lectureship in Child and Adolescent Psychiatry. Children`s Hospital of Michigan, Detroit Medical Center/Wayne State University 2002
- Mental Health Association`s Pamela Blumenthal Memorial Prism Award 2000
- ADDA-SR Award 1996
Books & Publications
-
Publications
-
The association between baseline insomnia symptoms and future suicide attempts within an intensive outpatient treatment program for suicide.
Lau JW, Stewart SM, King JD, Kennard BD, Emslie GJ, Psychiatry research 2019 Aug 112527 -
Psychotic Symptoms and Suicidal Ideation in Child and Adolescent Bipolar I Disorder.
Duffy ME, Gai AR, Rogers ML, Joiner TE, Luby JL, Joshi PT, Wagner KD, Emslie GJ, Walkup JT, Axelson D, Bipolar disorders 2019 Apr -
A Theory-Driven Investigation of the Association Between Emotion Dysregulation and Suicide Risk in a Clinical Adolescent Sample.
Eaddy M, Zullo L, Horton SE, Hughes JL, Kennard B, Diederich A, Emslie GJ, Schuster L, Stewart SM Suicide & life-threatening behavior 2018 May -
Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidality.
Mayes TL, Kennard BD, Killian M, Carmody T, Grannemann BD, Rush AJ, Jha MK, Hughes J, Emslie GJ, Trivedi MH Journal of affective disorders 2018 Mar 235 45-51 -
Predictors and Moderators of Relapse in Children and Adolescents With Major Depressive Disorder.
Kennard BD, Mayes TL, Chahal Z, Nakonezny PA, Moorehead A, Emslie GJ The Journal of clinical psychiatry 2018 Feb 79 2 -
Hopelessness as a Predictor of Suicide Ideation in Depressed Male and Female Adolescent Youth.
Wolfe KL, Nakonezny PA, Owen VJ, Rial KV, Moorehead AP, Kennard BD, Emslie GJ Suicide & life-threatening behavior 2017 Dec -
Comorbid sleep disorders and suicide risk among children and adolescents with bipolar disorder.
Stanley IH, Hom MA, Luby JL, Joshi PT, Wagner KD, Emslie GJ, Walkup JT, Axelson DA, Joiner TE Journal of psychiatric research 2017 Jul 95 54-59 -
The Interpersonal-Psychological Theory of Suicide in Adolescents: A Preliminary Report of Changes Following Treatment.
King JD, Horton SE, Hughes JL, Eaddy M, Kennard BD, Emslie GJ, Stewart SM Suicide & life-threatening behavior 2017 Mar -
Frequency and Methods of Nonsuicidal Self-Injury in Relation to Acquired Capability for Suicide Among Adolescents.
Matney J, Westers NJ, Horton SE, King JD, Eaddy M, Emslie GJ, Kennard BD, Stewart SM Archives of suicide research : official journal of the International Academy for Suicide Research 2017 Jan -
Effective Treatment of Depressive Disorders in Medical Clinics for Adolescents and Young Adults Living With HIV: A Controlled Trial.
Brown LK, Kennard BD, Emslie GJ, Mayes TL, Whiteley LB, Bethel J, Xu J, Thornton S, Tanney MR, Hawkins LA, Garvie PA, Subramaniam GA, Worrell CJ, Stoff LW Journal of acquired immune deficiency syndromes (1999) 2016 Jan 71 1 38-46 -
Pediatric Psychopharmacology Trials: Beyond Efficacy.
Emslie GJ The American journal of psychiatry 2015 Dec 172 12 1171-2 -
Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.
Emslie GJ, Kennard BD, Mayes TL, Nakonezny PA, Moore J, Jones JM, Foxwell AA, King J Journal of the American Academy of Child and Adolescent Psychiatry 2015 Dec 54 12 991-8 -
Cortical inhibitory and excitatory correlates of depression severity in children and adolescents.
Lewis CP, Nakonezny PA, Ameis SH, Vande Voort JL, Husain MM, Emslie GJ, Daskalakis ZJ, Croarkin PE Journal of affective disorders 2015 Oct 190 566-575 -
Acute and longer-term safety results from a pooled analysis of duloxetine studies for the treatment of children and adolescents with major depressive disorder.
Emslie GJ, Wells TG, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS Journal of child and adolescent psychopharmacology 2015 May 25 4 293-305 -
Predicting placebo response in adolescents with major depressive disorder: The Adolescent Placebo Impact Composite Score (APICS).
Nakonezny PA, Mayes TL, Byerly MJ, Emslie GJ Journal of psychiatric research 2015 May -
Sequential Treatment With Fluoxetine and Relapse-Prevention CBT to Improve Outcomes in Pediatric Depression.
Kennard BD, Emslie GJ, Mayes TL, Nakonezny PA, Jones JM, Foxwell AA, King J The American journal of psychiatry 2014 Jun -
A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
Emslie GJ, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS Journal of child and adolescent psychopharmacology 2014 May 24 4 170-9 -
A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder.
Atkinson SD, Prakash A, Zhang Q, Pangallo BA, Bangs ME, Emslie GJ, March JS Journal of child and adolescent psychopharmacology 2014 May 24 4 180-9 -
Developmental aspects of cortical excitability and inhibition in depressed and healthy youth: an exploratory study.
Croarkin PE, Nakonezny PA, Lewis CP, Zaccariello MJ, Huxsahl JE, Husain MM, Kennard BD, Emslie GJ, Daskalakis ZJ Frontiers in human neuroscience 2014 8 669 -
Evidence for Pretreatment LICI Deficits Among Depressed Children and Adolescents With Nonresponse to Fluoxetine.
Croarkin PE, Nakonezny PA, Husain MM, Port JD, Melton T, Kennard BD, Emslie GJ, Kozel FA, Daskalakis ZJ Brain stimulation 2013 Dec -
The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression.
Mansoor B, Rengasamy M, Hilton R, Porta G, He J, Spirito A, Emslie GJ, Mayes TL, Clarke G, Wagner KD, Shamseddeen W, Birmaher B, Ryan N, Brent D Journal of child and adolescent psychopharmacology 2013 Sep 23 7 458-67 -
Depressed Adolescents Treated with Exercise (DATE): A pilot randomized controlled trial to test feasibility and establish preliminary effect sizes.
Hughes CW, Barnes S, Barnes C, Defina LF, Nakonezny P, Emslie GJ Mental health and physical activity 2013 Jun 6 2 -
Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Hilton RC, Rengasamy M, Mansoor B, He J, Mayes T, Emslie GJ, Porta G, Clarke GN, Wagner KD, Birmaher B, Keller MB, Ryan N, Shamseddeen W, Asarnow JR, Brent DA Journal of the American Academy of Child and Adolescent Psychiatry 2013 May 52 5 482-92 -
The bi-directional relationship between parent-child conflict and treatment outcome in treatment-resistant adolescent depression.
Rengasamy M, Mansoor BM, Hilton R, Porta G, He J, Emslie GJ, Mayes T, Clarke GN, Wagner KD, Keller MB, Ryan ND, Birmaher B, Shamseddeen W, Asarnow JR, Brent DA Journal of the American Academy of Child and Adolescent Psychiatry 2013 Apr 52 4 370-7 -
Safety first.
Emslie GJ Bipolar disorders 2013 Mar 15 2 153-5 -
Evidence for Increased Glutamatergic Cortical Facilitation in Children and Adolescents With Major Depressive Disorder.
Croarkin PE, Nakonezny PA, Husain MM, Melton T, Buyukdura JS, Kennard BD, Emslie GJ, Kozel FA, Daskalakis ZJ JAMA psychiatry (Chicago, Ill.) 2013 Jan 1-9 -
Are adults just big children?
Emslie GJ The American journal of psychiatry 2012 Mar 169 3 248-50 -
Increased cortical excitability with prefrontal high-frequency repetitive transcranial magnetic stimulation in adolescents with treatment-resistant major depressive disorder.
Croarkin PE, Wall CA, Nakonezny PA, Buyukdura JS, Husain MM, Sampson SM, Emslie GJ, Kozel FA Journal of child and adolescent psychopharmacology 2012 Feb 22 1 56-64 -
Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth.
Emslie GJ, Kennard BD, Mayes TL, Nakonezny PA, Zhu L, Tao R, Hughes C, Croarkin P Journal of child and adolescent psychopharmacology 2012 Feb 22 1 21-8 -
Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
Shamseddeen W, Clarke G, Keller MB, Wagner KD, Birmaher B, Emslie GJ, Ryan N, Asarnow JR, Porta G, Brent DA Journal of child and adolescent psychopharmacology 2012 Feb 22 1 29-36 -
The psychopharmacology of adolescent depression.
Emslie GJ Journal of child and adolescent psychopharmacology 2012 Feb 22 1 2-4 -
Predictors of treatment response in adolescent depression.
Emslie GJ, Kennard BD, Mayes TL Pediatric annals 2011 Jun 40 6 300-6 -
Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes.
Emslie GJ, Mayes T, Porta G, Vitiello B, Clarke G, Wagner KD, Asarnow JR, Spirito A, Birmaher B, Ryan N, Kennard B, DeBar L, McCracken J, Strober M, Onorato M, Zelazny J, Keller M, Iyengar S, Brent D The American journal of psychiatry 2010 Jul 167 7 782-91 -
Escitalopram in the treatment of adolescent depression: a randomized placebo-controlled multisite trial.
Emslie GJ, Ventura D, Korotzer A, Tourkodimitris S Journal of the American Academy of Child and Adolescent Psychiatry 2009 Jul 48 7 721-9 -
Combination of cognitive behavioral therapy and sertraline is more effective than monotherapy for pediatric anxiety disorders.
Emslie GJ The Journal of pediatrics 2009 May 154 5 775-6 -
Understanding placebo response in pediatric depression trials.
Emslie GJ The American journal of psychiatry 2009 Jan 166 1 1-3 -
Pediatric anxiety--underrecognized and undertreated.
Emslie GJ The New England journal of medicine 2008 Dec 359 26 2835-6 -
Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.
Emslie GJ, Kennard BD, Mayes TL, Nightingale-Teresi J, Carmody T, Hughes CW, Rush AJ, Tao R, Rintelmann JW The American journal of psychiatry 2008 Apr 165 4 459-67 -
Improving outcome in pediatric depression.
Emslie GJ The American journal of psychiatry 2008 Jan 165 1 1-3 -
Antidepressant management in the context of suicidal ideation.
Emslie GJ, Waslick B, Weller EB, Kloos A, Weller RA, Kratochvil CJ Journal of the American Academy of Child and Adolescent Psychiatry 2007 Sep 46 9 1222-5 -
Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials.
Emslie GJ, Findling RL, Yeung PP, Kunz NR, Li Y Journal of the American Academy of Child and Adolescent Psychiatry 2007 Apr 46 4 479-88 -
Long-term, open-label venlafaxine extended-release treatment in children and adolescents with major depressive disorder.
Emslie GJ, Yeung PP, Kunz NR CNS spectrums 2007 Mar 12 3 223-33 -
Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial.
Emslie GJ, Wagner KD, Kutcher S, Krulewicz S, Fong R, Carpenter DJ, Lipschitz A, Machin A, Wilkinson C Journal of the American Academy of Child and Adolescent Psychiatry 2006 Jun 45 6 709-19 -
A feasibility study of the Childhood MDD Medication Algorithm: The Texas Children`s Medication Algorithm Project (CMAP).
Emslie, GJ, Hughes CW, Crismon ML, Lopez, M, Pliszka S, Toprac, M, Boemer C. Journal of the American Academy Child and Adolescent Psychiatry 2004 43(5) 519-27 -
Treatment for Adolescents with Depression Study (TADS): Rationale, design, and methods
Treatment for Adolescents with Depression Study Team Journal of the American Academy of Child & Adolescent Psychiatry 2003 42 531-542 -
Predictors of response to treatment in children and adolescents with mood disorders.
Emslie GJ, Mayes TL, Laptook RS, Batt M. The Psychiatric clinics of North America. Depression: Recent Developments and Innovative Treatments. Rosenbaum JF, Dunner DL (eds.). W.B. Saunders Company, Philadelphia, PA 2003 435-456 -
Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial.
Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SL, Ernest DE, Brown E, Neilsson M, Jacobson JG J Am Acad Child & Adolesc Psychiatry, 2002 41(10) 1205-1215 -
Mood disorders in children and adolescents: Psychopharmacological treatment
Emslie GJ, Mayes TL. Biol Psychiatry 2001 49 1082-1090 -
Fluoxetine in child and adolescent depression: Acute and maintenance treatment
Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Carmody T, Mayes TL Depression and Anxiety 1998 7 32-39 -
A double-blind, randomized, placebo-controlled study of fluoxetine in depressed children and adolescents
Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes, CW, Carmody T, Rintelmann JW Arch Gen Psychiatry 1997 54 1031-1037
-
The association between baseline insomnia symptoms and future suicide attempts within an intensive outpatient treatment program for suicide.
Research
- Integration of cognitive behavioral therapy (CBT) in the treatment of pediatric depression
- Pediatric depression
- Pharmacological treatment of depression in children and adolescents
- Suicidal behavior in youth
- Treatment-resistant depression